US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PagerDuty, Inc.

14.00

-0.4400-3.05%

Post-market: 13.95-0.0500-0.36%19:49 EDT

Volume:3.04M

Turnover:42.62M

Market Cap:1.10B

PE:6.90

High:14.52

Open:14.30

Low:13.95

Close:14.44

52wk High:16.91

52wk Low:5.70

Shares:78.65M

Float Shares:70.64M

Volume Ratio:2.23

T/O Rate:4.30%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.03

EPS(LYR):1.87

ROE:82.56%

ROA:2.29%

PB:4.75

PE(LYR):7.49

Loading ...

Overview Company News Filings

CSPC Launches Phase Ib/II Trial of Novel PD-1/IL-15 Fusion Drug for Liver Cancer in China

Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP

PagerDuty is Maintained at Sector Perform by RBC Capital

Press Release: Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results

RBC Capital Sticks to Its Hold Rating for PagerDuty (PD)

Press Release: PagerDuty to Report Second Quarter Fiscal Year 2027 Results on August 27, 2026

PagerDuty to Report Fiscal Q2 Results After Market Close

Press Release: Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update

AKESO (09926) Gains NMPA Nod for Third Indication of Its First-in-Class Bispecific Antibody, Ivonescimab, in Frontline Squamous NSCLC

BTIG Reiterates Buy on PIKTOR as New PK/PD Data De-Risk Development and Support Unchanged $55 Price Target

Press Release: Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update

Palisade Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of PALI-2108 Into Phase 2 Development

Press Release: Entera Announces Second Quarter 2026 Financial Results and Business Updates

Press Release: Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update

Alector Reports Second Quarter 2026 Financial Results and Provides Business Update

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals

Press Release: Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise

HENLIUS Receives NMPA Approval for Clinical Trial of HLX43 Combination Therapy in Advanced Solid Tumors

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/PD/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"PD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PD\",,,,,undefined,":{"symbol":"PD","market":"US","secType":"STK","nameCN":"PagerDuty, Inc.","latestPrice":14,"timestamp":1789761600000,"preClose":14.44,"halted":0,"volume":3035572,"hourTrading":{"tag":"盘后","latestPrice":13.95,"preClose":14,"latestTime":"19:49 EDT","volume":657783,"amount":9205317.32602,"timestamp":1789775385979,"change":-0.05,"changeRate":-0.003571,"amplitude":0.051429},"delay":0,"changeRate":-0.03047091412742379,"floatShares":70635553,"shares":78649873,"eps":2.03,"marketStatus":"Market Closed","change":-0.44,"latestTime":"09-18 16:00:00 EDT","open":14.3,"high":14.515,"low":13.95,"amount":42621452.570952,"amplitude":0.039127,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.03,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1554955200000,"exchange":"NYSE","adjPreClose":14.44,"preHourTrading":{"tag":"盘前","latestPrice":14.44,"preClose":14.44,"latestTime":"09:21 EDT","volume":9,"amount":130.269996,"timestamp":1789737673022,"change":0,"changeRate":0,"amplitude":0.021468},"postHourTrading":{"tag":"盘后","latestPrice":13.95,"preClose":14,"latestTime":"19:49 EDT","volume":657783,"amount":9205317.32602,"timestamp":1789775385979,"change":-0.05,"changeRate":-0.003571,"amplitude":0.051429},"volumeRatio":2.234036775207465,"impliedVol":0.5497,"impliedVolPercentile":0.1195},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PD\",,,,,undefined,":{"symbol":"PD","floatShares":70635553,"roa":"2.29%","roe":"82.56%","lyrEps":1.87,"volumeRatio":2.234036775207465,"shares":78649873,"dividePrice":0,"high":14.515,"amplitude":0.039127,"preClose":14.44,"low":13.95,"week52Low":5.7,"pbRate":"4.75","psRate":"2.23","week52High":16.91,"institutionHeld":0,"latestPrice":14,"eps":2.03,"divideRate":0,"volume":3035572,"delay":0,"ttmEps":2.03,"open":14.3,"prevYearClose":13.11,"prevWeekClose":14.09,"prevMonthClose":14.14,"prevQuarterClose":9.65,"fiveDayClose":14.09,"twentyDayClose":12.12,"sixtyDayClose":8.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PD\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"PD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/07","expectedEps":0.12,"defaultRemindTime":1787860800000,"name":null,"time":"Post-Mkt","dateTimestamp":1787803200000,"actualEps":null},{"market":"US","date":"2026-05-28","symbol":"PD","fiscalQuarterEnding":"2026/04","expectedEps":0.03,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1779940800000,"reportTimeType":"post","actualEps":0.1},{"market":"US","date":"2026-03-12","symbol":"PD","fiscalQuarterEnding":"2026/01","expectedEps":0.04,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":0.13},{"market":"US","date":"2025-11-25","symbol":"PD","fiscalQuarterEnding":"2025/10","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1764046800000,"reportTimeType":"post","actualEps":0.15},{"date":"2025-09-03","symbol":"PD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/07","expectedEps":-0.02,"defaultRemindTime":1756929600000,"name":null,"time":"Post-Mkt","dateTimestamp":1756872000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.3333,"hold":0.4444,"sell":0.2222,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.4444,"analysts":9,"updateTime":1784692800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PD","date":"2026-09-18","current":6.896552,"percent":0.959336,"low":-115.332138,"twenty":-29.002076,"median":-21.4373,"eighty":-16.309146,"high":9.29824,"avg":-23.568336,"sd":22.553203,"marketCap":1124164988},"quantilePoints":[{"date":"2021-09-24","current":-41.531159,"twenty":-63.322968,"median":-45.131991,"eighty":-39.806871,"marketCap":3944421825},{"date":"2021-10-01","current":-37.845067,"twenty":-63.294318,"median":-44.969953,"eighty":-39.673042,"marketCap":3594335269},{"date":"2021-10-08","current":-35.304169,"twenty":-63.234694,"median":-44.895964,"eighty":-39.361418,"marketCap":3353013468},{"date":"2021-10-15","current":-36.968279,"twenty":-62.977151,"median":-44.757709,"eighty":-39.195032,"marketCap":3511062253},{"date":"2021-10-22","current":-37.567716,"twenty":-62.673,"median":-44.689179,"eighty":-39.048237,"marketCap":3567993805},{"date":"2021-10-29","current":-37.352992,"twenty":-62.144822,"median":-44.662724,"eighty":-38.884343,"marketCap":3547600413},{"date":"2021-11-05","current":-38.927633,"twenty":-61.970673,"median":-44.622066,"eighty":-38.780249,"marketCap":3697151952},{"date":"2021-11-12","current":-37.684024,"twenty":-61.914834,"median":-44.517265,"eighty":-38.690435,"marketCap":3579040225},{"date":"2021-11-19","current":-34.892615,"twenty":-61.891288,"median":-44.350719,"eighty":-38.663132,"marketCap":3313926135},{"date":"2021-11-26","current":-33.094304,"twenty":-61.87812,"median":-44.340807,"eighty":-38.647574,"marketCap":3143131480},{"date":"2021-12-03","current":-27.717262,"twenty":-61.851785,"median":-44.310434,"eighty":-38.490518,"marketCap":2632446965},{"date":"2021-12-10","current":-29.437491,"twenty":-61.634212,"median":-44.193031,"eighty":-38.342002,"marketCap":2964590848},{"date":"2021-12-17","current":-29.446029,"twenty":-61.446371,"median":-44.130431,"eighty":-38.122419,"marketCap":2965450648},{"date":"2021-12-23","current":-30.863263,"twenty":-61.141525,"median":-44.120926,"eighty":-37.910083,"marketCap":3108177469},{"date":"2021-12-31","current":-29.668005,"twenty":-60.679678,"median":-44.096614,"eighty":-37.767931,"marketCap":2987805451},{"date":"2022-01-07","current":-27.243339,"twenty":-60.561077,"median":-44.020576,"eighty":-37.685906,"marketCap":2743622214},{"date":"2022-01-14","current":-26.466422,"twenty":-60.402519,"median":-43.931787,"eighty":-37.609143,"marketCap":2665380403},{"date":"2022-01-21","current":-25.715117,"twenty":-60.229637,"median":-43.82863,"eighty":-37.535067,"marketCap":2589717991},{"date":"2022-01-28","current":-27.448241,"twenty":-60.179262,"median":-43.748751,"eighty":-37.457573,"marketCap":2764257417},{"date":"2022-02-04","current":-27.106738,"twenty":-60.125395,"median":-43.643849,"eighty":-37.310047,"marketCap":2729865412},{"date":"2022-02-11","current":-28.728874,"twenty":-59.884929,"median":-43.550718,"eighty":-37.143446,"marketCap":2893227437},{"date":"2022-02-18","current":-27.106738,"twenty":-59.724487,"median":-43.492185,"eighty":-36.968378,"marketCap":2729865412},{"date":"2022-02-25","current":-28.071482,"twenty":-59.678646,"median":-43.437917,"eighty":-36.905651,"marketCap":2827022827},{"date":"2022-03-04","current":-25.322389,"twenty":-59.583656,"median":-43.360924,"eighty":-36.834452,"marketCap":2550167185},{"date":"2022-03-11","current":-22.70136,"twenty":-59.306192,"median":-43.319423,"eighty":-36.766338,"marketCap":2286208545},{"date":"2022-03-18","current":-28.291592,"twenty":-59.172166,"median":-43.295217,"eighty":-36.444632,"marketCap":3040073042},{"date":"2022-03-25","current":-28.785804,"twenty":-59.048339,"median":-43.241759,"eighty":-36.064649,"marketCap":3093178556},{"date":"2022-04-01","current":-27.724464,"twenty":-59.048339,"median":-43.1764,"eighty":-35.678665,"marketCap":2979132288},{"date":"2022-04-08","current":-25.415442,"twenty":-58.958192,"median":-43.086807,"eighty":-35.293402,"marketCap":2731016361},{"date":"2022-04-14","current":-26.428171,"twenty":-58.866018,"median":-43.039133,"eighty":-34.945236,"marketCap":2839839136},{"date":"2022-04-22","current":-23.843687,"twenty":-58.778063,"median":-42.940117,"eighty":-34.48789,"marketCap":2562123414},{"date":"2022-04-29","current":-23.14693,"twenty":-58.704534,"median":-42.888728,"eighty":-33.407653,"marketCap":2487253345},{"date":"2022-05-06","current":-21.039181,"twenty":-58.614907,"median":-42.82356,"eighty":-33.196501,"marketCap":2260765197},{"date":"2022-05-13","current":-21.537198,"twenty":-58.533862,"median":-42.744231,"eighty":-33.138326,"marketCap":2314279623},{"date":"2022-05-20","current":-19.528801,"twenty":-58.506847,"median":-42.67719,"eighty":-32.784627,"marketCap":2098467346},{"date":"2022-05-27","current":-21.055509,"twenty":-58.47232,"median":-42.506172,"eighty":-32.56425,"marketCap":2262519768},{"date":"2022-06-03","current":-19.41561,"twenty":-58.365647,"median":-42.492303,"eighty":-32.253988,"marketCap":2285547362},{"date":"2022-06-10","current":-18.661968,"twenty":-58.119439,"median":-42.449993,"eighty":-31.627913,"marketCap":2196830881},{"date":"2022-06-17","current":-17.871017,"twenty":-57.794408,"median":-42.412967,"eighty":-30.853018,"marketCap":2103722495},{"date":"2022-06-24","current":-21.251213,"twenty":-57.545961,"median":-42.37641,"eighty":-30.527663,"marketCap":2501629088},{"date":"2022-07-01","current":-18.975364,"twenty":-57.27835,"median":-42.328632,"eighty":-30.205871,"marketCap":2233722883},{"date":"2022-07-08","current":-20.758734,"twenty":-57.119373,"median":-42.300639,"eighty":-29.937792,"marketCap":2443655942},{"date":"2022-07-15","current":-19.512613,"twenty":-57.022546,"median":-42.274674,"eighty":-29.686169,"marketCap":2296966315},{"date":"2022-07-22","current":-19.751391,"twenty":-56.538634,"median":-42.258991,"eighty":-29.576542,"marketCap":2325074507},{"date":"2022-07-29","current":-19.348454,"twenty":-55.37095,"median":-42.1379,"eighty":-29.489533,"marketCap":2277641933},{"date":"2022-08-05","current":-21.340755,"twenty":-54.581356,"median":-41.999461,"eighty":-29.249821,"marketCap":2512169660},{"date":"2022-08-12","current":-21.370602,"twenty":-54.282209,"median":-41.907002,"eighty":-28.899625,"marketCap":2515683184},{"date":"2022-08-19","current":-19.214141,"twenty":-54.164004,"median":-41.742363,"eighty":-28.761236,"marketCap":2261831075},{"date":"2022-08-26","current":-19.318607,"twenty":-54.013801,"median":-41.687142,"eighty":-28.490216,"marketCap":2274128409},{"date":"2022-09-02","current":-16.562766,"twenty":-53.825684,"median":-41.612639,"eighty":-28.401837,"marketCap":2096100841},{"date":"2022-09-09","current":-17.753369,"twenty":-53.67791,"median":-41.5952,"eighty":-28.368118,"marketCap":2246777593},{"date":"2022-09-16","current":-16.597991,"twenty":-53.584381,"median":-41.569297,"eighty":-28.257217,"marketCap":2100558733},{"date":"2022-09-23","current":-15.858267,"twenty":-53.533149,"median":-41.530643,"eighty":-28.105632,"marketCap":2006943000},{"date":"2022-09-30","current":-16.252786,"twenty":-53.345477,"median":-41.466004,"eighty":-27.873415,"marketCap":2056871391},{"date":"2022-10-07","current":-16.182337,"twenty":-53.110426,"median":-41.390601,"eighty":-27.717262,"marketCap":2047955607},{"date":"2022-10-14","current":-14.646529,"twenty":-52.79331,"median":-41.34773,"eighty":-27.636067,"marketCap":1853591514},{"date":"2022-10-21","current":-16.485271,"twenty":-52.578578,"median":-41.307589,"eighty":-27.328715,"marketCap":2086293479},{"date":"2022-10-28","current":-17.922449,"twenty":-52.484531,"median":-41.281723,"eighty":-27.012825,"marketCap":2268175475},{"date":"2022-11-04","current":-14.604259,"twenty":-52.445692,"median":-41.223096,"eighty":-26.683037,"marketCap":1848242043},{"date":"2022-11-11","current":-17.35885,"twenty":-52.440537,"median":-41.165581,"eighty":-26.46868,"marketCap":2196849202},{"date":"2022-11-18","current":-15.442613,"twenty":-51.97825,"median":-41.046215,"eighty":-26.415612,"marketCap":1954339874},{"date":"2022-11-25","current":-15.379208,"twenty":-51.971496,"median":-40.952393,"eighty":-26.24103,"marketCap":1946315669},{"date":"2022-12-02","current":-16.042428,"twenty":-51.941247,"median":-40.886211,"eighty":-26.002015,"marketCap":2129728606},{"date":"2022-12-09","current":-16.110204,"twenty":-51.872986,"median":-40.837833,"eighty":-25.713912,"marketCap":2138726192},{"date":"2022-12-16","current":-18.028246,"twenty":-51.7604,"median":-40.772608,"eighty":-25.598799,"marketCap":2393357876},{"date":"2022-12-23","current":-17.994359,"twenty":-51.70784,"median":-40.745253,"eighty":-25.338499,"marketCap":2388859083},{"date":"2022-12-30","current":-18.001136,"twenty":-51.570726,"median":-40.701201,"eighty":-25.184081,"marketCap":2389758841},{"date":"2023-01-06","current":-16.049206,"twenty":-51.363479,"median":-40.623172,"eighty":-24.85486,"marketCap":2130628364},{"date":"2023-01-13","current":-18.78733,"twenty":-51.102161,"median":-40.574619,"eighty":-24.231092,"marketCap":2494130839},{"date":"2023-01-20","current":-18.882216,"twenty":-50.978262,"median":-40.523325,"eighty":-23.99114,"marketCap":2506727459},{"date":"2023-01-27","current":-19.925957,"twenty":-50.965686,"median":-40.469321,"eighty":-23.312385,"marketCap":2645290284},{"date":"2023-02-03","current":-21.220466,"twenty":-50.951221,"median":-40.311267,"eighty":-22.57339,"marketCap":2817144176},{"date":"2023-02-10","current":-19.627745,"twenty":-50.890949,"median":-40.250171,"eighty":-21.596594,"marketCap":2605700905},{"date":"2023-02-17","current":-20.664708,"twenty":-50.876484,"median":-40.190227,"eighty":-21.430411,"marketCap":2743363971},{"date":"2023-02-24","current":-19.485417,"twenty":-50.857197,"median":-40.120759,"eighty":-21.251213,"marketCap":2586805975},{"date":"2023-03-03","current":-20.834146,"twenty":-50.688437,"median":-40.045986,"eighty":-21.055509,"marketCap":2765857936},{"date":"2023-03-10","current":-18.204462,"twenty":-50.646894,"median":-39.953806,"eighty":-20.967665,"marketCap":2416751599},{"date":"2023-03-17","current":-22.814647,"twenty":-50.628165,"median":-39.81605,"eighty":-20.881589,"marketCap":2929925462},{"date":"2023-03-24","current":-22.508745,"twenty":-50.547877,"median":-39.758269,"eighty":-20.937818,"marketCap":2890640524},{"date":"2023-03-31","current":-24.884826,"twenty":-50.538628,"median":-39.648544,"eighty":-20.967665,"marketCap":3195783993},{"date":"2023-04-06","current":-22.608341,"twenty":-50.398102,"median":-39.410762,"eighty":-20.985573,"marketCap":2903430969},{"date":"2023-04-14","current":-23.753697,"twenty":-50.260054,"median":-39.321908,"eighty":-21.029355,"marketCap":3050521084},{"date":"2023-04-21","current":-24.273021,"twenty":-50.211876,"median":-39.198908,"eighty":-21.041663,"marketCap":3117214118},{"date":"2023-04-28","current":-22.053448,"twenty":-50.10983,"median":-39.086878,"eighty":-21.052864,"marketCap":2832169920},{"date":"2023-05-05","current":-20.085339,"twenty":-50.030853,"median":-39.045525,"eighty":-21.029355,"marketCap":2579419472},{"date":"2023-05-12","current":-21.254175,"twenty":-50.011348,"median":-38.97946,"eighty":-20.981096,"marketCap":2729524925},{"date":"2023-05-19","current":-21.074906,"twenty":-49.936988,"median":-38.858126,"eighty":-20.935287,"marketCap":2706502616},{"date":"2023-05-26","current":-18.98821,"twenty":-49.739821,"median":-38.781427,"eighty":-20.865452,"marketCap":2438522942},{"date":"2023-06-02","current":-23.7011,"twenty":-49.634889,"median":-38.748697,"eighty":-20.83367,"marketCap":2555476271},{"date":"2023-06-09","current":-19.16437,"twenty":-49.587066,"median":-38.685442,"eighty":-20.780404,"marketCap":2066321490},{"date":"2023-06-16","current":-19.591955,"twenty":-49.518553,"median":-38.668128,"eighty":-20.758997,"marketCap":2112424156},{"date":"2023-06-23","current":-18.642716,"twenty":-49.490829,"median":-38.652026,"eighty":-20.740419,"marketCap":2010076237},{"date":"2023-06-30","current":-18.830853,"twenty":-49.425691,"median":-38.650282,"eighty":-20.728887,"marketCap":2030361410},{"date":"2023-07-07","current":-18.753888,"twenty":-49.321753,"median":-38.534252,"eighty":-20.640309,"marketCap":2022062930},{"date":"2023-07-14","current":-21.12271,"twenty":-49.135663,"median":-38.486364,"eighty":-20.586625,"marketCap":2277471700},{"date":"2023-07-21","current":-20.626711,"twenty":-49.077653,"median":-38.375503,"eighty":-20.595005,"marketCap":2223992607},{"date":"2023-07-28","current":-21.105606,"twenty":-49.061015,"median":-38.330676,"eighty":-20.595005,"marketCap":2275627593},{"date":"2023-08-04","current":-20.883262,"twenty":-49.007339,"median":-38.158206,"eighty":-20.613914,"marketCap":2251654207},{"date":"2023-08-11","current":-20.549746,"twenty":-48.954208,"median":-37.988814,"eighty":-20.586625,"marketCap":2215694127},{"date":"2023-08-18","current":-20.01954,"twenty":-48.941266,"median":-37.845067,"eighty":-20.541194,"marketCap":2158526822},{"date":"2023-08-25","current":-20.66947,"twenty":-48.894876,"median":-37.770349,"eighty":-20.506987,"marketCap":2228602874},{"date":"2023-09-01","current":-25.511357,"twenty":-48.832826,"median":-37.755599,"eighty":-20.541194,"marketCap":2375209352},{"date":"2023-09-07","current":-24.043412,"twenty":-48.807682,"median":-37.686377,"eighty":-20.560008,"marketCap":2238537799},{"date":"2023-09-14","current":-23.412009,"twenty":-48.750972,"median":-37.671633,"eighty":-20.577111,"marketCap":2179751687},{"date":"2023-09-22","current":-22.590183,"twenty":-48.595885,"median":-37.578261,"eighty":-20.58462,"marketCap":2103236431},{"date":"2023-09-28","current":-22.048981,"twenty":-48.583225,"median":-37.547623,"eighty":-20.587293,"marketCap":2052848336},{"date":"2023-10-05","current":-21.978825,"twenty":-48.576545,"median":-37.531928,"eighty":-20.595005,"marketCap":2046316545},{"date":"2023-10-11","current":-21.497757,"twenty":-48.562801,"median":-37.500901,"eighty":-20.605423,"marketCap":2001527127},{"date":"2023-10-20","current":-20.345196,"twenty":-48.534663,"median":-37.448341,"eighty":-20.589221,"marketCap":1894219146},{"date":"2023-10-27","current":-19.894194,"twenty":-48.514606,"median":-37.410785,"eighty":-20.580532,"marketCap":1852229066},{"date":"2023-11-03","current":-20.485508,"twenty":-48.433814,"median":-37.299311,"eighty":-20.506205,"marketCap":1907282726},{"date":"2023-11-10","current":-20.746087,"twenty":-48.370598,"median":-37.219715,"eighty":-20.506987,"marketCap":1931543661},{"date":"2023-11-17","current":-21.217133,"twenty":-48.32991,"median":-37.120374,"eighty":-20.524091,"marketCap":1975399966},{"date":"2023-11-24","current":-21.858558,"twenty":-48.320008,"median":-37.057747,"eighty":-20.549746,"marketCap":2035119191},{"date":"2023-11-30","current":-22.048981,"twenty":-48.252059,"median":-36.968279,"eighty":-20.57027,"marketCap":2052848336},{"date":"2023-12-07","current":-26.625426,"twenty":-48.121131,"median":-36.925787,"eighty":-20.578821,"marketCap":2015198621},{"date":"2023-12-15","current":-28.276615,"twenty":-48.00719,"median":-36.911135,"eighty":-20.582242,"marketCap":2140172179},{"date":"2024-01-05","current":-26.103359,"twenty":-47.918569,"median":-36.904212,"eighty":-20.585288,"marketCap":1975684923},{"date":"2024-01-12","current":-31.117632,"twenty":-47.865829,"median":-36.842529,"eighty":-20.591149,"marketCap":2355200212},{"date":"2024-01-19","current":-31.627558,"twenty":-47.844972,"median":-36.829603,"eighty":-20.601178,"marketCap":2393794988},{"date":"2024-01-26","current":-29.053645,"twenty":-47.78321,"median":-36.766338,"eighty":-20.619869,"marketCap":2198983265},{"date":"2024-02-02","current":-29.32075,"twenty":-47.731847,"median":-36.504107,"eighty":-20.628421,"marketCap":2219199576},{"date":"2024-02-09","current":-29.393596,"twenty":-47.672575,"median":-36.388531,"eighty":-20.635263,"marketCap":2224713115},{"date":"2024-02-16","current":-29.733547,"twenty":-47.618326,"median":-36.095963,"eighty":-20.635379,"marketCap":2250442965},{"date":"2024-02-23","current":-28.10664,"twenty":-47.602066,"median":-35.89466,"eighty":-20.635842,"marketCap":2127307254},{"date":"2024-03-01","current":-29.332891,"twenty":-47.570415,"median":-35.678665,"eighty":-20.651153,"marketCap":2220118499},{"date":"2024-03-08","current":-29.55143,"twenty":-47.518149,"median":-35.35785,"eighty":-20.660918,"marketCap":2236659117},{"date":"2024-03-15","current":-26.009561,"twenty":-47.49129,"median":-35.24315,"eighty":-20.664708,"marketCap":2126463652},{"date":"2024-03-22","current":-25.786705,"twenty":-47.380514,"median":-34.925503,"eighty":-20.66947,"marketCap":2108243640},{"date":"2024-03-28","current":-24.935846,"twenty":-47.342533,"median":-34.589879,"eighty":-20.66947,"marketCap":2038679948},{"date":"2024-04-05","current":-25.071983,"twenty":-47.312176,"median":-34.414946,"eighty":-20.689994,"marketCap":2049810139},{"date":"2024-04-12","current":-25.888808,"twenty":-47.269427,"median":-33.423363,"eighty":-20.697474,"marketCap":2116591283},{"date":"2024-04-19","current":-23.631195,"twenty":-47.158961,"median":-33.184171,"eighty":-20.697474,"marketCap":1932015619},{"date":"2024-04-26","current":-22.916473,"twenty":-46.951231,"median":-33.003753,"eighty":-20.698257,"marketCap":1873582118},{"date":"2024-05-03","current":-23.897861,"twenty":-46.656905,"median":-32.649248,"eighty":-20.698257,"marketCap":1953817432},{"date":"2024-05-10","current":-23.114516,"twenty":-46.598159,"median":-32.247909,"eighty":-20.698257,"marketCap":1889773514},{"date":"2024-05-17","current":-24.517522,"twenty":-46.43348,"median":-31.759443,"eighty":-20.698257,"marketCap":2004479038},{"date":"2024-05-24","current":-22.904066,"twenty":-46.181838,"median":-31.451512,"eighty":-20.698257,"marketCap":1872567685},{"date":"2024-05-31","current":-20.986625,"twenty":-46.068748,"median":-31.128449,"eighty":-20.698257,"marketCap":1715803469},{"date":"2024-06-07","current":-20.224161,"twenty":-45.830813,"median":-30.643949,"eighty":-20.66395,"marketCap":1892880316},{"date":"2024-06-14","current":-21.429439,"twenty":-45.725202,"median":-30.31849,"eighty":-20.645029,"marketCap":2005688335},{"date":"2024-06-21","current":-21.357939,"twenty":-45.671397,"median":-29.967092,"eighty":-20.641966,"marketCap":1998996334},{"date":"2024-06-28","current":-23.247571,"twenty":-45.51108,"median":-29.932669,"eighty":-20.635726,"marketCap":2175856364},{"date":"2024-07-05","current":-22.542789,"twenty":-45.42729,"median":-29.794252,"eighty":-20.635726,"marketCap":2109892353},{"date":"2024-07-12","current":-21.439653,"twenty":-45.27192,"median":-29.668005,"eighty":-20.635726,"marketCap":2006644335},{"date":"2024-07-15","current":-21.807365,"twenty":-45.165128,"median":-29.6527,"eighty":-20.635726,"marketCap":2041060341},{"date":"2024-08-02","current":-20.438659,"twenty":-44.67116,"median":-29.473821,"eighty":-20.619869,"marketCap":1912956320},{"date":"2024-08-09","current":-18.937169,"twenty":-44.592228,"median":-29.326821,"eighty":-20.554877,"marketCap":1772424296},{"date":"2024-08-16","current":-19.846234,"twenty":-44.342086,"median":-29.065787,"eighty":-20.488395,"marketCap":1857508310},{"date":"2024-08-23","current":-19.366166,"twenty":-44.293477,"median":-28.968658,"eighty":-20.439367,"marketCap":1812576303},{"date":"2024-08-30","current":-20.193518,"twenty":-44.126836,"median":-28.878841,"eighty":-20.396729,"marketCap":1890012316},{"date":"2024-09-06","current":-20.851386,"twenty":-44.070828,"median":-28.815003,"eighty":-20.350301,"marketCap":1731811836},{"date":"2024-09-13","current":-19.495653,"twenty":-43.902513,"median":-28.750118,"eighty":-20.261779,"marketCap":1619211496},{"date":"2024-09-20","current":-20.358392,"twenty":-43.724824,"median":-28.493474,"eighty":-20.244564,"marketCap":1690866258},{"date":"2024-09-27","current":-20.324779,"twenty":-43.52784,"median":-28.425739,"eighty":-20.226358,"marketCap":1688074514},{"date":"2024-10-04","current":-19.753355,"twenty":-43.367535,"median":-28.373476,"eighty":-20.209123,"marketCap":1640614867},{"date":"2024-10-11","current":-20.30237,"twenty":-43.311657,"median":-28.264591,"eighty":-20.195561,"marketCap":1686213351},{"date":"2024-10-18","current":-21.030656,"twenty":-43.248031,"median":-28.136018,"eighty":-20.195561,"marketCap":1746701137},{"date":"2024-10-25","current":-20.078282,"twenty":-43.248031,"median":-28.049113,"eighty":-20.145499,"marketCap":1667601725},{"date":"2024-10-31","current":-20.649706,"twenty":-43.248031,"median":-27.765641,"eighty":-20.132647,"marketCap":1715061372},{"date":"2024-11-08","current":-22.688907,"twenty":-43.252213,"median":-27.636067,"eighty":-20.132233,"marketCap":1884427173},{"date":"2024-11-15","current":-21.960621,"twenty":-43.252213,"median":-27.448241,"eighty":-20.132233,"marketCap":1823939387},{"date":"2024-11-22","current":-22.229527,"twenty":-43.231304,"median":-27.106738,"eighty":-20.132233,"marketCap":1846273338},{"date":"2024-11-29","current":-25.707412,"twenty":-43.145724,"median":-26.876224,"eighty":-20.132233,"marketCap":1914893729},{"date":"2024-12-06","current":-25.40483,"twenty":-43.145724,"median":-26.625426,"eighty":-20.132233,"marketCap":1892354961},{"date":"2024-12-13","current":-24.521289,"twenty":-43.145724,"median":-26.466422,"eighty":-20.132233,"marketCap":1826541758},{"date":"2024-12-20","current":-22.572657,"twenty":-43.145724,"median":-26.327469,"eighty":-20.132233,"marketCap":1681392092},{"date":"2024-12-27","current":-22.173248,"twenty":-43.145724,"median":-26.203648,"eighty":-20.132233,"marketCap":1651640919},{"date":"2025-01-03","current":-21.785943,"twenty":-43.145724,"median":-26.12294,"eighty":-20.132233,"marketCap":1622791296},{"date":"2025-01-10","current":-21.434947,"twenty":-43.151859,"median":-25.994723,"eighty":-20.130744,"marketCap":1596646325},{"date":"2025-01-17","current":-22.584761,"twenty":-43.151859,"median":-25.832017,"eighty":-20.130744,"marketCap":1682293643},{"date":"2025-01-24","current":-22.584761,"twenty":-43.151859,"median":-25.722549,"eighty":-20.130744,"marketCap":1682293643},{"date":"2025-01-31","current":-22.330591,"twenty":-43.151859,"median":-25.688138,"eighty":-20.130744,"marketCap":1663361078},{"date":"2025-02-07","current":-23.032583,"twenty":-43.151859,"median":-25.544418,"eighty":-20.130744,"marketCap":1715651020},{"date":"2025-02-14","current":-23.601438,"twenty":-43.151859,"median":-25.410136,"eighty":-20.130744,"marketCap":1758023904},{"date":"2025-02-21","current":-22.149042,"twenty":-43.151859,"median":-25.353801,"eighty":-20.130744,"marketCap":1649837817},{"date":"2025-02-28","current":-21.229191,"twenty":-43.151859,"median":-25.248903,"eighty":-20.130744,"marketCap":1581319962},{"date":"2025-03-07","current":-20.902402,"twenty":-43.157994,"median":-25.114351,"eighty":-20.129255,"marketCap":1556978093},{"date":"2025-03-14","current":-25.841364,"twenty":-43.157994,"median":-25.015259,"eighty":-20.118618,"marketCap":1407320673},{"date":"2025-03-21","current":-31.526661,"twenty":-43.157994,"median":-25.094673,"eighty":-20.118618,"marketCap":1716941957},{"date":"2025-03-28","current":-31.810986,"twenty":-43.157994,"median":-25.094673,"eighty":-20.118618,"marketCap":1732426315},{"date":"2025-04-04","current":-28.415807,"twenty":-43.157994,"median":-25.140052,"eighty":-20.118618,"marketCap":1547524873},{"date":"2025-04-11","current":-25.672904,"twenty":-43.151859,"median":-25.115856,"eighty":-20.120859,"marketCap":1398146368},{"date":"2025-04-17","current":-25.238054,"twenty":-43.151859,"median":-25.115856,"eighty":-20.120859,"marketCap":1374464410},{"date":"2025-04-25","current":-26.22483,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1428204238},{"date":"2025-05-02","current":-26.007405,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1416363259},{"date":"2025-05-09","current":-26.208105,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1427293394},{"date":"2025-05-16","current":-28.064582,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1528397138},{"date":"2025-05-23","current":-26.826931,"twenty":-43.110374,"median":-25.054079,"eighty":-20.118618,"marketCap":1460994642},{"date":"2025-05-30","current":-40.212905,"twenty":-43.110374,"median":-25.054079,"eighty":-20.118618,"marketCap":1483896395},{"date":"2025-06-06","current":-38.417271,"twenty":-42.89345,"median":-25.054079,"eighty":-20.118618,"marketCap":1417635735},{"date":"2025-06-13","current":-37.443101,"twenty":-42.85482,"median":-25.054079,"eighty":-20.118618,"marketCap":1381687885},{"date":"2025-06-20","current":-35.644634,"twenty":-42.692819,"median":-25.045717,"eighty":-20.116377,"marketCap":1315322623},{"date":"2025-06-27","current":-37.218293,"twenty":-42.4845,"median":-25.045717,"eighty":-20.116377,"marketCap":1373392227},{"date":"2025-07-03","current":-39.940973,"twenty":-42.385562,"median":-25.045717,"eighty":-20.116377,"marketCap":1473861860},{"date":"2025-07-11","current":-39.516335,"twenty":-42.275719,"median":-25.045717,"eighty":-20.116377,"marketCap":1458192284},{"date":"2025-07-18","current":-36.593825,"twenty":-42.275719,"median":-25.045717,"eighty":-20.116377,"marketCap":1350348733},{"date":"2025-07-25","current":-36.743697,"twenty":-42.001222,"median":-25.045717,"eighty":-20.116377,"marketCap":1355879172},{"date":"2025-08-01","current":-40.265697,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1485844477},{"date":"2025-08-08","current":-38.941825,"twenty":-41.552011,"median":-25.045717,"eighty":-20.116377,"marketCap":1436992270},{"date":"2025-08-15","current":-38.667059,"twenty":-41.27534,"median":-25.045717,"eighty":-20.116377,"marketCap":1426853133},{"date":"2025-08-22","current":-39.441399,"twenty":-41.020287,"median":-25.045717,"eighty":-20.116377,"marketCap":1455427065},{"date":"2025-08-29","current":-42.263994,"twenty":-40.940123,"median":-25.045717,"eighty":-20.116377,"marketCap":1559583657},{"date":"2025-09-05","current":-111.301894,"twenty":-40.946258,"median":-25.037354,"eighty":-20.114136,"marketCap":1545092897},{"date":"2025-09-12","current":-111.369065,"twenty":-41.159237,"median":-25.045717,"eighty":-20.116377,"marketCap":1546025361},{"date":"2025-09-19","current":-110.361504,"twenty":-41.502219,"median":-25.045717,"eighty":-20.116377,"marketCap":1532038401},{"date":"2025-09-26","current":-108.816577,"twenty":-41.627318,"median":-25.045717,"eighty":-20.116377,"marketCap":1510591728},{"date":"2025-10-03","current":-110.630187,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1535768257},{"date":"2025-10-10","current":-109.824138,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1524578689},{"date":"2025-10-17","current":-105.659553,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1466765919},{"date":"2025-10-24","current":-107.540334,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1492874912},{"date":"2025-10-31","current":-105.793895,"twenty":-41.746269,"median":-25.045717,"eighty":-20.116377,"marketCap":1468630847},{"date":"2025-11-07","current":-101.562139,"twenty":-41.812397,"median":-25.045717,"eighty":-20.116377,"marketCap":1409885613},{"date":"2025-11-14","current":-104.719163,"twenty":-41.812397,"median":-25.045717,"eighty":-20.116377,"marketCap":1453711422},{"date":"2025-11-21","current":-98.740968,"twenty":-41.812397,"median":-25.045717,"eighty":-20.116377,"marketCap":1370722124},{"date":"2025-11-28","current":6.997444,"twenty":-41.746269,"median":-24.978468,"eighty":-20.091839,"marketCap":1065227860},{"date":"2025-12-05","current":7.219871,"twenty":-41.569584,"median":-24.845699,"eighty":-20.051536,"marketCap":1099088196},{"date":"2025-12-12","current":7.833049,"twenty":-41.149298,"median":-24.524361,"eighty":-20.010479,"marketCap":1192432905},{"date":"2025-12-19","current":7.79698,"twenty":-40.783904,"median":-24.456235,"eighty":-19.933106,"marketCap":1186942040},{"date":"2025-12-26","current":7.839061,"twenty":-40.638471,"median":-24.290539,"eighty":-19.921421,"marketCap":1193348049},{"date":"2026-01-02","current":7.881142,"twenty":-40.445544,"median":-24.213538,"eighty":-19.883804,"marketCap":1199754059},{"date":"2026-01-09","current":7.616633,"twenty":-40.245714,"median":-24.133436,"eighty":-19.850083,"marketCap":1159487714},{"date":"2026-01-16","current":7.105652,"twenty":-40.140803,"median":-24.036721,"eighty":-19.806911,"marketCap":1081700456},{"date":"2026-01-23","current":6.738947,"twenty":-40.000922,"median":-23.900481,"eighty":-19.757821,"marketCap":1025876659},{"date":"2026-01-30","current":6.318139,"twenty":-39.844633,"median":-23.836174,"eighty":-19.718173,"marketCap":961816564},{"date":"2026-02-06","current":4.749124,"twenty":-39.429144,"median":-23.74822,"eighty":-19.674843,"marketCap":722963925},{"date":"2026-02-13","current":4.075831,"twenty":-39.135469,"median":-23.649661,"eighty":-19.608912,"marketCap":620467774},{"date":"2026-02-20","current":4.021727,"twenty":-38.923318,"median":-23.601935,"eighty":-19.561129,"marketCap":612231476},{"date":"2026-02-27","current":4.256177,"twenty":-38.673097,"median":-23.492961,"eighty":-19.508534,"marketCap":647922100},{"date":"2026-03-06","current":4.664962,"twenty":-38.60711,"median":-23.396809,"eighty":-19.489511,"marketCap":710151906},{"date":"2026-03-13","current":3.826831,"twenty":-38.317356,"median":-23.305813,"eighty":-19.445457,"marketCap":665309840},{"date":"2026-03-20","current":3.358288,"twenty":-37.997629,"median":-23.223191,"eighty":-19.406656,"marketCap":583851876},{"date":"2026-03-27","current":3.07113,"twenty":-37.726969,"median":-23.142007,"eighty":-19.330546,"marketCap":533928310},{"date":"2026-04-02","current":3.075998,"twenty":-37.531928,"median":-23.103807,"eighty":-19.288759,"marketCap":534774472},{"date":"2026-04-10","current":2.95432,"twenty":-37.33152,"median":-23.026783,"eighty":-19.228348,"marketCap":513620418},{"date":"2026-04-17","current":3.119801,"twenty":-37.141321,"median":-22.922472,"eighty":-19.200424,"marketCap":542389931},{"date":"2026-04-24","current":2.998124,"twenty":-36.968415,"median":-22.886122,"eighty":-19.150518,"marketCap":521235878},{"date":"2026-05-01","current":3.236611,"twenty":-36.792556,"median":-22.796862,"eighty":-19.059356,"marketCap":562697823},{"date":"2026-05-08","current":3.60651,"twenty":-36.546214,"median":-22.703577,"eighty":-18.989041,"marketCap":627006145},{"date":"2026-05-15","current":2.967148,"twenty":-36.114067,"median":-22.620757,"eighty":-18.890004,"marketCap":515850488},{"date":"2026-05-22","current":3.10823,"twenty":-35.890938,"median":-22.561376,"eighty":-18.847957,"marketCap":540378298},{"date":"2026-05-29","current":3.010498,"twenty":-35.390059,"median":-22.540072,"eighty":-18.78733,"marketCap":573791883},{"date":"2026-06-05","current":3.84405,"twenty":-34.84372,"median":-22.428622,"eighty":-18.581645,"marketCap":732664367},{"date":"2026-06-12","current":3.548665,"twenty":-32.834795,"median":-22.336643,"eighty":-18.476527,"marketCap":676364895},{"date":"2026-06-18","current":3.487969,"twenty":-32.200072,"median":-22.276208,"eighty":-18.281834,"marketCap":664796510},{"date":"2026-06-26","current":3.463691,"twenty":-31.676123,"median":-22.229527,"eighty":-18.139398,"marketCap":660169156},{"date":"2026-07-02","current":4.058507,"twenty":-31.506957,"median":-22.173248,"eighty":-18.004593,"marketCap":773539326},{"date":"2026-07-10","current":4.232501,"twenty":-31.379147,"median":-22.100628,"eighty":-17.925594,"marketCap":806702029},{"date":"2026-07-17","current":4.309382,"twenty":-30.85814,"median":-22.017878,"eighty":-17.790437,"marketCap":821355317},{"date":"2026-07-24","current":3.492016,"twenty":-30.583371,"median":-21.935122,"eighty":-17.680267,"marketCap":665567735},{"date":"2026-07-31","current":4.196084,"twenty":-30.20705,"median":-21.898647,"eighty":-17.533486,"marketCap":799760999},{"date":"2026-08-07","current":4.491469,"twenty":-29.939946,"median":-21.843368,"eighty":-17.408164,"marketCap":856060471},{"date":"2026-08-14","current":4.892059,"twenty":-29.794252,"median":-21.785943,"eighty":-17.253175,"marketCap":932411810},{"date":"2026-08-21","current":4.904198,"twenty":-29.6527,"median":-21.707843,"eighty":-16.923368,"marketCap":934725487},{"date":"2026-08-28","current":5.299253,"twenty":-29.522867,"median":-21.601223,"eighty":-16.727101,"marketCap":983255111},{"date":"2026-09-04","current":5.91603,"twenty":-29.332891,"median":-21.539711,"eighty":-16.640261,"marketCap":1097695730},{"date":"2026-09-11","current":5.769178,"twenty":-29.150774,"median":-21.490433,"eighty":-16.485271,"marketCap":1070447963},{"date":"2026-09-18","current":6.058686,"twenty":-29.002076,"median":-21.4373,"eighty":-16.309146,"marketCap":1124164988}],"updateTime":1789823861000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PD\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660142874","title":"CSPC Launches Phase Ib/II Trial of Novel PD-1/IL-15 Fusion Drug for Liver Cancer in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2660142874","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660142874?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:18","pubTimestamp":1787141913,"startTime":"0","endTime":"0","summary":"An update from CSPC Pharmaceutical Group ( ($HK:1093) ) is now available. CSPC Pharmaceutical Group has officially initiated a Phase Ib/II clinical...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cspc-launches-phase-ib-ii-trial-of-novel-pd-1-il-15-fusion-drug-for-liver-cancer-in-china?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cspc-launches-phase-ib-ii-trial-of-novel-pd-1-il-15-fusion-drug-for-liver-cancer-in-china?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","LU1169589451.USD","LU1169590202.USD","PD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660467809","title":"Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660467809","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660467809?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:30","pubTimestamp":1787056200,"startTime":"0","endTime":"0","summary":"Avance Clinical to Lead Preparatory Activities for Multi-Center Investigation Across AustraliaMELBOURNE, Australia, Aug.  18, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/18/3346826/0/en/propanc-biopharma-clears-path-for-world-first-phase-1b-clinical-study-of-breakthrough-cancer-therapy-prp.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4218","IE00BYQQ9H92.USD","LU1169589451.USD","LU1169590202.USD","LU2413666699.HKD","BK4585","BK4533","IE00BFXG0V08.USD","LU1093756325.SGD","LU1093756168.USD","MTD","PD","LU2413666426.HKD","BK4567","BK4548","BK4181","PK","LU0347712357.USD","BK4023","KBWY","LU2211817866.USD","BK4121","LU1721428933.USD","IE00B5TLWC47.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659514739","title":"PagerDuty is Maintained at Sector Perform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2659514739","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659514739?lang=en_us&edition=fundamental","pubTime":"2026-08-14 22:14","pubTimestamp":1786716840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PD/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU1169589451.USD","LU1169590202.USD","LU1267930573.SGD","BK4207","PD","LU0310800379.SGD","LU0708994859.HKD","LU0029864427.USD","GSIB","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659099146","title":"Press Release: Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659099146","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659099146?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:01","pubTimestamp":1786708860,"startTime":"0","endTime":"0","summary":"-- Pivotal Phase 3 Alzheimer's disease  trial is fully enrolled with a. total number of 850 patients, exceeding original projections.-- Parkinson's disease  open-label extension  study has enrolled. 266 patients with full enrollment projected in Q4 2026.-- Annovis will host a corporate update webinar on Wednesday, September 2,-- Patients: The pivotal Phase 3 AD trial includes patients diagnosed with. early AD  who are also positive for plasma pTau217 biomarker,confirming the presence of amyloid and tau pathology in the brain.-- Study design: The study measures cognition  and function. pTau217, and other biomarkers to evaluate changes in disease pathology.The study is designed to test both symptomatic  and. -- Timeline: The Company plans a database lock for the 6-month analysis in. Q1 2027, with the top-line symptomatic data readout anticipated in the. same quarter. The disease-modifying data readout is expected a year. later.Alzheimer's disease -- OLE study-- Start: The AD OLE study is","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169590202.USD","BK4023","LU1169589451.USD","BK4139","ANVS","PD","DBS","BK4132","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659149831","title":"RBC Capital Sticks to Its Hold Rating for PagerDuty (PD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659149831","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659149831?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:55","pubTimestamp":1786708546,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Matthew Hedberg from RBC Capital maintained a Hold rating on PagerDuty, with a price target of $12.00. The company’...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-hold-rating-for-pagerduty-pd-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-hold-rating-for-pagerduty-pd-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167848","title":"Press Release: PagerDuty to Report Second Quarter Fiscal Year 2027 Results on August 27, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167848","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167848?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:12","pubTimestamp":1786651920,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO--(BUSINESS WIRE)--August 13, 2026--PagerDuty, Inc. (NYSE:PD), a leader in digital operations management, today announced it will release its financial results for the second quarter fisc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","LU1169590202.USD","PD","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659621271","title":"PagerDuty to Report Fiscal Q2 Results After Market Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2659621271","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659621271?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:08","pubTimestamp":1786651683,"startTime":"0","endTime":"0","summary":"PagerDuty to report fiscal Q2 results after market closePagerDuty schedules second-quarter fiscal 2027 results release for Aug. 27, 2026.Investor conference call set for Aug. 27, 2026 at 2:00 p.m. PT ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL6CFr13:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PD","BK4023","LU1169590202.USD","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659733155","title":"Press Release: Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659733155","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659733155?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"--  The Company initiated the Phase 2a/2b trial of YB-101 in patients with. Graves' disease , with or without concurrent thyroid eye disease. --  The Phase 2a portion of the trial is a randomized,four cohorts designed to evaluate safety, pharmacokinetics ,pharmacodynamics , and efficacy over 24 weeks, including the. percentage of patients who are euthyroid and off anti-thyroid. drugs, as well as relevant measures of orbitopathy in patients. --  Topline results from the Phase 2a portion of the trial are. --  The Phase 2b portion of the trial is expected to commence in the. --  Licensing partner, Changchun GeneScience Pharmaceutical Co., Ltd.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SHLD","BK4566","PD","BK4187","FOWF","PK","WDGF","GD","BK4550","TSHR","BK4588","PPA","BK4516","LU1169590202.USD","KBWY","BK4181","LU1169589451.USD","YB","BK4218","LU0170899867.USD","BK4023","IDEF","BK4173","BK4585","YARW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147433388","title":"AKESO (09926) Gains NMPA Nod for Third Indication of Its First-in-Class Bispecific Antibody, Ivonescimab, in Frontline Squamous NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1147433388","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147433388?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:11","pubTimestamp":1786540312,"startTime":"0","endTime":"0","summary":"AKESO (09926) has announced that its independently developed, globally first-in-class bispecific antibody, Ivonescimab (marketed as Yidaifang®), has received approval from the China National Medical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","LU1169589451.USD","KURE","IE00B5MMRT66.SGD","LU2399975544.HKD","LU2476274720.SGD","LU1169590202.USD","LU1720050803.USD","09926","IPOS","IE00B543WZ88.USD","LU0348825331.USD","BK4023","LU0348784397.USD","LU0561508036.HKD","LU2778985437.USD","LU1961090484.USD","LU0348783233.USD","LU2476274308.USD","IE00BPRC5H50.USD","BK1161","LU0348827113.USD","LU0348766576.USD","LU0417516902.SGD","LU0417516738.SGD","LU0634319403.HKD","LU0540923850.HKD","LU2488822045.USD","LU1794554557.SGD","LU0348767384.USD","LU0417516571.SGD","PD","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658268992","title":"BTIG Reiterates Buy on PIKTOR as New PK/PD Data De-Risk Development and Support Unchanged $55 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2658268992","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658268992?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:15","pubTimestamp":1786446936,"startTime":"0","endTime":"0","summary":"Analyst Jeet Mukherjee from BTIG maintained a Buy rating on Faeth Therapeutics and keeping the price target at $55.00. Jeet Mukherjee has given his...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/btig-reiterates-buy-on-piktor-as-new-pk-pd-data-de-risk-development-and-support-unchanged-55-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/btig-reiterates-buy-on-piktor-as-new-pk-pd-data-de-risk-development-and-support-unchanged-55-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PK","PD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658994051","title":"Press Release: Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658994051","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658994051?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446000,"startTime":"0","endTime":"0","summary":"at the 3rd International GBA1 Meeting 2026 in May 2026 in Phoenix, AZ.-- As of May 2026, all 16 participants enrolled in the Phase 1b,nine-month extension remained on study and had completed five. -- MDS-UPDRS scores remained stable and durable across the overall. study population after 150 days of treatment with rexaceract.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","PD","BK4139","BK4023","LU1169590202.USD","CSF","INN","BK4119","BK4181","IND","BK4604","TM","BK4555","BK4585","GT","BK4218","BK4588","GANX","LU1169589451.USD","BK4099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658952508","title":"Palisade Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of PALI-2108 Into Phase 2 Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2658952508","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658952508?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:20","pubTimestamp":1786393200,"startTime":"0","endTime":"0","summary":"Advancing a potentially best-in-class once-daily oral, locally-activated PDE4 inhibitor prodrug specifically engineered for the treatment of inflammatory bowel disease (IBD) Enrollment of first patien","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/10/3342259/0/en/palisade-bio-reports-second-quarter-2026-financial-results-and-highlights-continued-advancement-of-pali-2108-into-phase-2-development.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443622.USD","IDNA","IND","LU1363072403.SGD","IE00BKVL7J92.USD","IE00BHPRN162.USD","LU0170899867.USD","LU2746668974.SGD","GDOC","LU0267386448.USD","LU1169589451.USD","BK4007","CMC","CD","PD","LU0971096721.USD","BK4116","LU2237443465.HKD","LU1169590202.USD","HYLG","LU2237443382.USD","BK4139","BK4023","IE00B1BXHZ80.USD","IE00BFXG1179.USD","PALI","LU0882574139.USD","LU2237443978.SGD","MEDX","LU2237443895.HKD","BK4127","IE00BZ1G4Q59.USD","LU0149725797.USD","NVIB","LU2237443549.SGD","LU2746668461.USD","IBD","BK4006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657626861","title":"Press Release: Entera Announces Second Quarter 2026 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657626861","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657626861?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:05","pubTimestamp":1786133100,"startTime":"0","endTime":"0","summary":"In June 2026, Entera announced that the FDA accepted Entera's plan to. conduct a single, randomized, double-blind, placebo-controlled Phase 3. trial in approximately 750 postmenopausal women with osteoporosis, with a","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169590202.USD","ENTX","IND","BK4232","PK","BK4022","KBWY","BK4181","PD","BK4023","KOL","LU1169589451.USD","R","BK4139","BK4218"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657610803","title":"Press Release: Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657610803","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657610803?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:00","pubTimestamp":1786100400,"startTime":"0","endTime":"0","summary":"Q2 2026 revenue of $29.1 million; GAAP basic EPS: $(0.12)Full year 2026 revenue guidance of $100.5 to $111.0 million affirmedNDA for F351 (hydronidone) for CHB-induced liver fibrosis accepted by China","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","BK4099","LU1223083913.SGD","CEO","03160","LU1169590202.USD","BK4604","TM","BK4585","SIL","PD","IND","BK4139","CHB","BK4588","XME","BK4017","CFO","CDE","BK4023","GYRE","SGDM","LU1169589451.USD","LU1223082519.USD","LU1223082196.USD","GDXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657614066","title":"Alector Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657614066","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657614066?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:05","pubTimestamp":1786046700,"startTime":"0","endTime":"0","summary":"Advancing the Alector Brain Carrier (ABC) blood-brain barrier platform across antibodies, enzymes, and siRNA, with AL137 advancing as Alector’s lead ABC-enabled anti-amyloid beta(Aβ) antibody program ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/06/3340733/0/en/Alector-Reports-Second-Quarter-2026-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","AD","BK4132","PD","BK4023","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657570414","title":"Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2657570414","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657570414?lang=en_us&edition=fundamental","pubTime":"2026-08-06 08:53","pubTimestamp":1785977580,"startTime":"0","endTime":"0","summary":"NANJING, China, Aug.  05, 2026  (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that its Phase II clinical study evaluating ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/06/3339882/0/en/Leads-Biolabs-Opamtistomig-PD-L1-4-1BB-Bispecific-Antibody-Advances-to-Expansion-Phase-in-First-Line-Hepatocellular-Carcinoma-Following-Positive-Efficacy-Signals.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BITU","MNRS","BTF","BFJL","BTCZ","COAL","DFII","CBTY","CBXO","BTCI","MAXI","PD","CBXY","BAGY","BTFX","DEFI","OC","BTCC","BETE","BTCL","CBOO","BITO","EZBC","ODD","BRRR","BFAP","BTRN","CBOA","BITX","BITB","BTCW","CBXJ","HCC","YBTC","BITY","GBTC","XHB","BTC","BTCO","HODL","BPI","BETH","SBIT","CBOJ","CBXA","CBOY","BCCC","CBTA","BITI","CBTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656378594","title":"Press Release: Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale","url":"https://stock-news.laohu8.com/highlight/detail?id=2656378594","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656378594?lang=en_us&edition=fundamental","pubTime":"2026-08-03 18:30","pubTimestamp":1785753000,"startTime":"0","endTime":"0","summary":"-- Combines highly complementary businesses, with a diversified portfolio of. CNS medicines totaling approximately $2.2 billion in combined annual. -- Enhanced financial position and free cash flow generation enabling. greater financial flexibility to pursue internal and external growth. -- Combined company expected to benefit from immediate scale and $125. -- Combined entity to be named Supernus, Inc. and Jack Khattar to serve as. The combined company will have a commercial portfolio of 11. differentiated medicines across psychiatry, neurology and addiction, with","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPD","BK4135","LU1169589451.USD","LU1169590202.USD","SUPN","PD","BK4007","BK4121","BK4530","ADHD","CNS","BK4561","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656134744","title":"Leads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise","url":"https://stock-news.laohu8.com/highlight/detail?id=2656134744","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656134744?lang=en_us&edition=fundamental","pubTime":"2026-08-03 11:43","pubTimestamp":1785728580,"startTime":"0","endTime":"0","summary":"NANJING, China, Aug.  02, 2026  (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that the Center for Drug Evaluation (CDE) of","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/03/3337201/0/en/Leads-Biolabs-PD-L1-4-1BB-Bispecific-Antibody-IND-Application-for-Combination-Therapy-in-Metastatic-Colorectal-Cancer-Approved-Further-Strengthening-Gastrointestinal-Oncology-Franc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QBF","IDNA","BETH","CBXY","BTCZ","XBTY","CBTA","BTRN","MNRS","BITX","XME","GDXJ","ODD","PD","FBTC","BFJL","BTCO","BITU","BTCW","DEFI","BRRR","OC","ARKB","CBXO","YBTC","BITI","CBXA","COAL","EZBC","CRC","BCCC","CBOA","IND","CBTJ","CBTO","BTCI","BTC","CBXJ","SIL","CDE","HCC","BTCL","BITO","HODL","MAXI","SGDM","XHB","MSS","BITY","CBOJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124877391","title":"HENLIUS Receives NMPA Approval for Clinical Trial of HLX43 Combination Therapy in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1124877391","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124877391?lang=en_us&edition=fundamental","pubTime":"2026-07-31 16:42","pubTimestamp":1785487323,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) has announced that the National Medical Products Administration (NMPA) has approved its clinical trial application for HLX43, a PD-L1-targeting antibody-drug conjugate (ADC), used in...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU1169590202.USD","BK1161","HK0000306685.HKD","BMED","IBBJ","BK4023","HK0000320264.USD","LU1169589451.USD","MDTX","PD","HK0000306701.USD","IBBQ","02696","HK0000320223.HKD","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655871524","title":"Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2655871524","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655871524?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:36","pubTimestamp":1785407760,"startTime":"0","endTime":"0","summary":"NANJING, China, July  30, 2026  (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) announced that the Phase II clinical study of its core produ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/30/3335874/0/en/Leads-Biolabs-Opamtistomig-PD-L1-4-1BB-Bispecific-Antibody-Completes-Patient-Enrollment-in-Phase-II-Study-for-Biliary-Tract-Cancer-Further-Demonstrating-Breakthrough-Potential-in-I.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}